The
G protein-coupled
ghrelin receptor GHSR1a is a potential pharmacological target for treating
obesity and addiction because of the critical role
ghrelin plays in energy homeostasis and
dopamine-dependent reward. GHSR1a enhances
growth hormone release, appetite, and
dopamine signaling through G(q/11), G(i/o), and G(12/13) as well as β-
arrestin-based scaffolds. However, the contribution of individual
G protein and β-
arrestin pathways to the diverse physiological responses mediated by
ghrelin remains unknown. To characterize whether a signaling bias occurs for GHSR1a, we investigated
ghrelin signaling in a number of cell-based assays, including Ca(2+) mobilization,
serum response factor response element, stress fiber formation, ERK1/2 phosphorylation, and β-
arrestin translocation, utilizing intracellular second loop and C-tail mutants of GHSR1a. We observed that GHSR1a and β-
arrestin rapidly form metastable plasma membrane complexes following exposure to an agonist, but replacement of the GHSR1a C-tail by the tail of the
vasopressin 2 receptor greatly stabilizes them, producing complexes observable on the plasma membrane and also in endocytic vesicles. Mutations of the contiguous conserved
amino acids Pro-148 and Leu-149 in the GHSR1a intracellular second loop generate receptors with a strong bias to
G protein and β-
arrestin, respectively, supporting a role for conformation-dependent signaling bias in the wild-type receptor. Our results demonstrate more balance in GHSR1a-mediated ERK signaling from
G proteins and β-
arrestin but uncover an important role for β-
arrestin in RhoA activation and stress fiber formation. These findings suggest an avenue for modulating
drug abuse-associated changes in synaptic plasticity via GHSR1a and indicate the development of GHSR1a-biased
ligands as a promising strategy for selectively targeting downstream signaling events.